CD32a is a Marker of a CD4 T-cell HIV Reservoir Harbouring Replication-competent Proviruses
Authors
Affiliations
The persistence of the HIV reservoir in infected individuals is a major obstacle to the development of a cure for HIV. Here, using an in vitro model of HIV-infected quiescent CD4 T cells, we reveal a gene expression signature of 103 upregulated genes that are specific for latently infected cells, including genes for 16 transmembrane proteins. In vitro screening for surface expression in HIV-infected quiescent CD4 T cells shows that the low-affinity receptor for the immunoglobulin G Fc fragment, CD32a, is the most highly induced, with no detectable expression in bystander cells. Notably, productive HIV-1 infection of T-cell-receptor-stimulated CD4 T cells is not associated with CD32a expression, suggesting that a quiescence-dependent mechanism is required for its induction. Using blood samples from HIV-1-positive participants receiving suppressive antiretroviral therapy, we identify a subpopulation of 0.012% of CD4 T cells that express CD32a and host up to three copies of HIV DNA per cell. This CD32a reservoir was highly enriched in inducible replication-competent proviruses and can be predominant in some participants. Our discovery that CD32a lymphocytes represent the elusive HIV-1 reservoir may lead to insights that will facilitate the specific targeting and elimination of this reservoir.
Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.
Chen W, Berkhout B, Pasternak A Curr HIV/AIDS Rep. 2025; 22(1):15.
PMID: 39903363 PMC: 11794352. DOI: 10.1007/s11904-025-00723-6.
Single cell spatial profiling of FFPE splenic tissue from a humanized mouse model of HIV infection.
Wu G, Keller S, Sardo L, Magliaro B, Zuck P, Balibar C Biomark Res. 2024; 12(1):116.
PMID: 39380117 PMC: 11462831. DOI: 10.1186/s40364-024-00658-x.
HIV Reservoirs and Treatment Strategies toward Curing HIV Infection.
Matsuda K, Maeda K Int J Mol Sci. 2024; 25(5).
PMID: 38473868 PMC: 10932120. DOI: 10.3390/ijms25052621.
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?.
Harper J, Betts M, Lichterfeld M, Muller-Trutwin M, Margolis D, Bar K Pathog Immun. 2024; 8(2):115-157.
PMID: 38455668 PMC: 10919397. DOI: 10.20411/pai.v8i2.665.
Zhang X, Qazi A, Deshmukh S, Lobato Ventura R, Mukim A, Beliakova-Bethell N Front Cell Infect Microbiol. 2023; 13:1286168.
PMID: 38156317 PMC: 10754520. DOI: 10.3389/fcimb.2023.1286168.